Eye Care - Czechia

  • Czechia
  • Revenue in the Eye Care market amounts to US$18.08m in 2024. The market is expected to grow annually by 3.08% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,256m in 2024).
  • In relation to total population figures, per person revenues of US$1.72 are generated in 2024.

Key regions: Canada, Thailand, Philippines, Worldwide, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in Czechia is experiencing significant growth due to changing customer preferences and trends in the market. Customer preferences in the Eye Care market have shifted towards a greater emphasis on preventative and proactive eye care.

Customers are becoming more aware of the importance of regular eye examinations and are seeking out products and services that can help maintain good eye health. This trend is driven by a growing concern for eye-related issues such as digital eye strain and age-related vision problems. As a result, there is an increased demand for products such as eye drops, vitamins, and supplements that promote eye health.

Additionally, customers are seeking out specialized eye care services such as laser eye surgery and vision correction procedures. Trends in the Eye Care market in Czechia are also influenced by global and regional market developments. The increasing prevalence of digital devices and screens in everyday life has led to a rise in cases of digital eye strain.

This has created a demand for products and services that address this specific issue, such as blue light blocking glasses and eye drops designed to relieve eye fatigue. Furthermore, the aging population in Czechia has contributed to the growth of the Eye Care market, as older individuals are more likely to experience age-related vision problems and require specialized eye care solutions. Local special circumstances in Czechia also play a role in the development of the Eye Care market.

The country has a well-established healthcare system that provides access to eye care services for a large portion of the population. This accessibility, combined with a high level of awareness about the importance of eye health, has contributed to the growth of the market. Additionally, Czechia has a strong tradition of optical manufacturing, with several local companies producing high-quality eyewear and contact lenses.

This has created a competitive market environment and has led to the availability of a wide range of eye care products and services. Underlying macroeconomic factors such as GDP growth and disposable income levels also contribute to the development of the Eye Care market in Czechia. As the economy continues to grow, consumers have more purchasing power and are willing to spend on products and services that promote their overall well-being, including eye care.

Additionally, the increasing urbanization and modernization of Czechia have led to lifestyle changes that can impact eye health, such as longer hours spent in front of screens and increased exposure to air pollution. These factors contribute to the demand for eye care products and services. In conclusion, the Eye Care market in Czechia is experiencing growth due to changing customer preferences, global and regional market trends, local special circumstances, and underlying macroeconomic factors.

The emphasis on preventative and proactive eye care, the increasing prevalence of digital devices, the aging population, and the accessibility of eye care services all contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)